Intelligence Platform

Patents

Browse 2,465 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 7862811

Protease inhibition for prevention or treatment of heart failure

The Regents of the University of Colorado · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7863414

Methods of treatment and uses for CaMKII and its interaction with HDACs and calpain

The Board of Regents of the University of Texas System · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7863262

Nitroxyl progenitors in the treatment of heart failure

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7863047

Intracorporeal medicaments for photodynamic treatment of disease

Provectus Pharmatech, Inc. · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7855190

Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen ad

TEVA WOMEN'S HEALTH, INC. · Granted Tue Dec 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7850970

Inhibitors of serine protease activity and their use in methods and compositions for treat

The Regents of the University of Colorado · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7851506

Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatme

Jazz Pharmaceuticals, Inc. · Granted Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7846664

Diagnosis and treatment of chronic lymphocytic leukemia (CLL)

The Regents of the University of California · Granted Tue Dec 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7838531

Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosc

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Nov 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7829279

Compositions and methods for diagnosis and treatment of epilepsy

The Regents of the University of California · Granted Tue Nov 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7825092

Dendroaspis natriuretic peptide for treatment of cancer

United States Department of Veteran Affairs · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7825102

Treatment of dry eye conditions

CAN-FITE BIOPHARMA LTD. · Granted Tue Nov 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7816324

Composition and method for the treatment of diseases affected by a peptide receptor

The Board of Regents of the University of Texas System · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7815921

Cytocapacity test for the prediction of the hematopoietic recovery, neutropenic fever, and

Ludwig-Maximilians-Universitat Munchen · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7815914

Methods for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7811996

Methods and compositions for prevention and treatment of inflammatory disease, autoimmune

The Regents of the University of California · Granted Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7807781

Inhibitors of serine protease activity and their use in methods and compositions for treat

The Regents of the University of Colorado · Granted Tue Oct 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7803380

Compositions and methods for diagnosis and treatment of tumors

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7803940

Heteromonocyclic compound or a salt thereof having strong antihypertensive action, insulin

Takeda Pharmaceutical Company Limited · Granted Tue Sep 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7799329

Viruses for the treatment of cellular proliferative disorders

ONCOLYTICS BIOTECH INC. · Granted Tue Sep 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7784616

Dispenser for progestin used for acute maintenance treatment of DUB

TEVA WOMEN'S HEALTH, INC. · Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7781449

Trospium chloride treatment method

Supernus Pharmaceuticals, Inc. · Granted Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7776883

Quinolin-4-ones as inhibitors of retroviral integrase for the treatment of HIV, AIDS and A

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7776827

Method of using substance P analogs for treatment amelioration of myelodysplastic syndrome

ImmuneRegen Biosciences, Inc. · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted